Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTA Announces New Center of Excellence at Duke University Hospital
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease (CMT), is thrilled…
Fall 2024 CMTA Report: Unity. Strength. Progress.
…issue covers transformative programs like Camp Footprint, which fosters leadership and confidence in young people with CMT, and recaps the 2024 CMTA Patient & Research Summit, where groundbreaking research and…
Type 2 Update: One Patient’s Diagnostic Odyssey with SORD
…scholar from University College of London— discovered the SORD mutation “hidden” from the gene analysis software that most researchers use. Using a different strategy, the researchers found the relevant variations…
Volunteer Spotlight: Amy Keller
…covered with the CMTA STARS Amy has sold to raise funds for CMT research. One fateful day, Amy recalls, she decided she was tired of feeling down about her diagnosis…
CMTA Volunteer Spotlight
…that the best way to live with CMT is by working to raise awareness, help fund research and create community with other CMTers. My most treasured volunteer role is with…
New Gene Therapy Development Program for CMT2A
…that it has licensed a sixth gene therapy development program under its research, collaboration and license agreement with the University of Pennsylvania and its Gene Therapy Program (GTP). The license…
Types of CMT
…because, by nerve conduction characteristics, it is neither demyelinating nor axonal – it is somewhere in between – it is intermediate. Learn more about how CMTA is accelerating research for…
CMTA-Funded Study on 3-D Printing Technique for Comparing CMT Heel Surgeries Named Game Changer at AAOS Meeting
…the second phase of the research to see what type of reconstructive procedure is best. That research should be completed in six months. One in 2,500 people has the genetic…
Invitae Announces Major Expansion of Its Neurology Test Offerings
…17 existing neurology panels based on new discoveries in genetics research. With this latest expansion of its test offerings, Invitae will be able to provide clinicians, patients, and payers with…
New Mobile App Simplifies Sign-Up for Patient Registry
A new mobile app developed by the Rare Diseases Clinical Research Network (RDCRN) makes it easier than ever for CMT patients to sign up for and navigate the network’s patient…